On May 8, 2019, moxifloxacin hydrochloride and sodium chloride injection, the latest generation of quinolones antibacterial drug, independently researched and developed by Qidu Pharmaceutical Co., Ltd

From 25 to 28 December 2019, workshop 801 in Qidu Pharma, which produces PP ampoule, was under on-site inspection from GMP experts of Shandong Drug Administration.

From May 8 to 29, 2020, the second QA director training class of Qidu Pharmaceutical was successfully held. Chairman Zheng Jiaqing, General Manager Zhang Jianli, and other company leaders attended the

At present, Qidu Pharma has successfully passed the certification site inspections of "ISO45001 Occupational Health and Safety Management System" and "ISO50001 Energy Management System" organized by S

On June 17, 2019, the 10th CPhI China-World CEO Summit was held in Shanghai. The China Chamber of Commerce for Import and Export of Medicines and Health Products released “The 4th Top 100 Internationa